| Nov 13 |
Fennec Pharmaceuticals to Participate in Upcoming Investor Conference
|
| Nov 12 |
Fennec Pharmaceuticals Third Quarter 2024 Earnings: Misses Expectations
|
| Nov 7 |
Fennec Pharmaceuticals GAAP EPS of -$0.21 misses by $0.12, revenue of $6.97M misses by $2.01M
|
| Nov 7 |
Fennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
|
| Oct 31 |
Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024
|
| Oct 29 |
Individual investors account for 31% of Fennec Pharmaceuticals Inc.'s (NASDAQ:FENC) ownership, while hedge funds account for 30%
|
| Oct 28 |
Fennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company’s Next Stage of Growth
|
| Oct 1 |
The past three years for Fennec Pharmaceuticals (NASDAQ:FENC) investors has not been profitable
|
| Aug 21 |
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Analysts Are Reducing Their Forecasts For This Year
|
| Aug 13 |
Fennec Pharmaceuticals Inc. (FENC) Q2 2024 Earnings Call Transcript
|
